Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Skin surface proteins and barrier components refer to the complex assembly of proteins, lipids, and enzymes within the stratum corneum that maintain the skin's physical and chemical integrity (StatPearls, NBK513299). Key structural proteins include filaggrin, loricrin, and involucrin, which form the cornified envelope, while lipids such as ceramides, cholesterol, and free fatty acids create a hydrophobic seal (PubMed, PMC5967208). These components collectively prevent transepidermal water loss (TEWL) and protect against environmental pathogens, allergens, and irritants (NIH, PMC2843412). Dysregulation or genetic mutations in these components, particularly filaggrin (FLG), are central to the pathogenesis of inflammatory skin diseases like atopic dermatitis and various forms of ichthyosis (UniProt, P20930). Therapeutic strategies often focus on replenishing these components through topical emollients or modulating the enzymes, such as kallikreins, involved in desquamation to restore barrier function (PubMed, PMC5608132). Additionally, the acidic pH of the skin surface, maintained by these components, is crucial for antimicrobial defense and enzyme activity (PubMed, PMC4471124). Modern pharmacological interventions aim to not only provide a passive barrier but also to stimulate the endogenous production of these essential proteins and lipids (PubMed, PMC3033356).
Restoration of lipid bilayer integrity, humectant-mediated hydration, and enzymatic regulation of desquamation to improve skin barrier function.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Skin surface proteins and barrier components.